+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032- Product Image
Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032- Product Image
New

Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122548
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The implantable contraceptive drug-eluting devices market is experiencing dynamic change as healthcare priorities shift toward long-acting, minimally invasive contraceptive solutions that enhance patient adherence and simplify care delivery. Senior decision-makers face evolving competitive, regulatory, and operational challenges as demand for reliable, engineered long-acting contraception grows worldwide.

Market Snapshot: Growth Outlook for Implantable Contraceptive Drug-Eluting Devices

The Implantable Contraceptive Drug Eluting Devices Market grew from USD 483.21 million in 2025 to USD 508.52 million in 2026. It is expected to continue growing at a CAGR of 5.54%, reaching USD 705.05 million by 2032.

Adoption is fueled by increasing preference for sustained, reversible contraception, ongoing investment in polymer-based technology, and a focus on comprehensive lifecycle evidence from both providers and payers.

Scope & Segmentation

This report offers a detailed examination of the implantable contraceptive drug-eluting devices sector, focusing on technology integration, channel strategies, and regional market dynamics across key segments:

  • Product Types: Multi-rod systems and single-rod systems, each with distinct insertion, removal, and workflow requirements for healthcare providers.
  • Active Ingredients: Focus on etonogestrel- and levonorgestrel-based implants, featuring different legacy footprints and clinical performance profiles.
  • Duration of Action: Coverage of products spanning 1–3 years, 3–5 years, and longer-term formats aligning with patient flexibility or long-term planning needs.
  • End Users: Insights into hospitals, specialty clinics, and public health agencies, each with unique procurement and clinical integration pathways.
  • Distribution Channels: Analysis of reach and patient access via hospital, retail, and online pharmacies, highlighting operational and regulatory nuances.
  • Regions: Coverage includes the Americas, Europe Middle East & Africa, and Asia-Pacific, revealing how local reimbursement, training capacity, and cultural context affect adoption and execution.
  • Technologies: Review of polymer engineering, controlled drug-release science, and removal-simplifying design advances shaping the next generation of products.

Key Takeaways: Strategies and Market Drivers

  • Demand is driven by the need for convenient, sustained contraceptive solutions that reduce the daily management burden for users and providers.
  • Market success increasingly depends on robust lifecycle evidence, post-market surveillance, and real-world patient support, reflecting tighter scrutiny from regulators and payers.
  • Competitive differentiation stems from integrated therapy platforms that combine polymer science, hormonal control, and ergonomic device design for seamless insertion and removal.
  • Manufacturers and channel partners must adapt to diverse regulatory, reimbursement, and supply environments, as operating contexts vary significantly across geographies.
  • Collaborations and multidisciplinary partnerships between drug developers, device engineers, and contract manufacturers are essential to respond quickly to changing requirements and to support technology and service innovation.

Tariff Impact: Navigating 2025 US Trade Challenges

Expected US tariff changes in 2025, alongside broader trade-policy uncertainty, are set to increase cost and complexity throughout implantable contraceptive device supply chains. Even domestically assembled products are exposed to sourcing friction, affecting medical-grade polymers, APIs, sterilization materials, and tooling. To mitigate these, firms are:

  • Accelerating supplier requalification and pursuing dual-sourcing to protect against input disruptions.
  • Re-engineering product packaging and configurations to optimize logistics and cost recovery.
  • Prioritizing procurement strategies focused on total cost of ownership, reliability, and quality assurance.
  • Integrating tariff management with broader risk planning, supply mapping, and scenario-based inventory approaches to sustain continuity and customer trust.

Methodology & Data Sources

Research is anchored in structured interviews with manufacturers, clinicians, procurers, and regulatory experts, supported by rigorous review of regulatory filings, company disclosures, clinical literature, and institutionally curated data. Insights are triangulated and verified with domain specialists for practical, decision-ready accuracy.

Why This Report Matters

  • Empowers executive teams to allocate R&D, capacity, and commercialization resources against real-world constraints and opportunities.
  • Guides supply chain, risk, and procurement leaders in developing resilient sourcing and operational models in a changing regulatory and trade environment.
  • Informs commercial, clinical, and policy-facing teams about region-specific market access, training, and adoption strategies.

Conclusion

Senior leaders in the implantable contraceptive drug-eluting devices market must balance innovation, supply chain resilience, and clinical credibility to respond to dynamic global demands. Integrating robust strategy throughout the lifecycle will help secure sustainable growth and market trust.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Implantable Contraceptive Drug Eluting Devices Market, by Product Type
8.1. Multi Rod
8.2. Single Rod
9. Implantable Contraceptive Drug Eluting Devices Market, by Drug Type
9.1. Etonogestrel
9.2. Levonorgestrel
10. Implantable Contraceptive Drug Eluting Devices Market, by End User
10.1. Clinics
10.1.1. Private Clinics
10.1.2. Public Clinics
10.2. Family Planning Centers
10.3. Hospitals
11. Implantable Contraceptive Drug Eluting Devices Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Implantable Contraceptive Drug Eluting Devices Market, by Polymer Material
12.1. Biodegradable
12.2. Non-Biodegradable
13. Implantable Contraceptive Drug Eluting Devices Market, by Duration
13.1. Five Year
13.2. Three Year
14. Implantable Contraceptive Drug Eluting Devices Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Implantable Contraceptive Drug Eluting Devices Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Implantable Contraceptive Drug Eluting Devices Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Implantable Contraceptive Drug Eluting Devices Market
18. China Implantable Contraceptive Drug Eluting Devices Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. 3Daughters, Inc.
19.6. AbbVie Inc.
19.7. Allergan, Inc.
19.8. Bayer AG
19.9. Boston Scientific Corporation
19.10. Celanese Corporation
19.11. Daré Bioscience, Inc.
19.12. DKT International
19.13. Femasys, Inc.
19.14. Gedeon Richter Plc.
19.15. Johnson & Johnson Services, Inc.
19.16. Lubrizol Life Science, Inc.
19.17. Medicines360
19.18. Medtronic plc
19.19. Mithra Pharmaceuticals SA
19.20. OCON Medical, Inc.
19.21. Organon & Co.
19.22. Pregna International Ltd.
19.23. Shanghai Dahua Pharmaceutical Co., Ltd.
19.24. The Cooper Companies, Inc.
List of Figures
FIGURE 1. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY MULTI ROD, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY MULTI ROD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY MULTI ROD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY SINGLE ROD, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY SINGLE ROD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY SINGLE ROD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY ETONOGESTREL, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY ETONOGESTREL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY ETONOGESTREL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY LEVONORGESTREL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY LEVONORGESTREL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY LEVONORGESTREL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PUBLIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PUBLIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY FAMILY PLANNING CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY FAMILY PLANNING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY FAMILY PLANNING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY NON-BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY NON-BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY FIVE YEAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY FIVE YEAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY FIVE YEAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY THREE YEAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY THREE YEAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY THREE YEAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 87. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 92. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 93. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 94. EUROPE IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 103. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 106. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 108. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 110. AFRICA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 123. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 125. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 127. ASEAN IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 128. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 131. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 133. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 135. GCC IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 144. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 147. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 149. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 151. BRICS IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 152. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 155. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 157. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 159. G7 IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 160. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 162. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 163. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 165. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 167. NATO IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)
TABLE 177. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 178. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 180. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 182. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY POLYMER MATERIAL, 2018-2032 (USD MILLION)
TABLE 184. CHINA IMPLANTABLE CONTRACEPTIVE DRUG ELUTING DEVICES MARKET SIZE, BY DURATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Implantable Contraceptive Drug Eluting Devices market report include:
  • 3Daughters, Inc.
  • AbbVie Inc.
  • Allergan, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Celanese Corporation
  • Daré Bioscience, Inc.
  • DKT International
  • Femasys, Inc.
  • Gedeon Richter Plc.
  • Johnson & Johnson Services, Inc.
  • Lubrizol Life Science, Inc.
  • Medicines360
  • Medtronic plc
  • Mithra Pharmaceuticals SA
  • OCON Medical, Inc.
  • Organon & Co.
  • Pregna International Ltd.
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • The Cooper Companies, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 508.52 Million
Forecasted Market Value ( USD ) by 2032 $ 705.05 Million
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032 - Product Image

Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Implantable Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Drug Eluting Implants Market - Forecasts from 2025 to 2030 - Product Image

Drug Eluting Implants Market - Forecasts from 2025 to 2030

  • Report
  • 148 Pages
  • Global
From
Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Non-Hormonal Contraceptives Market Report 2025 - Product Image

Non-Hormonal Contraceptives Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.